Advertisement

Interleukin-8 —A Mediator of Inflammatory Lung Disease?

  • Diana Smith
  • Lisa Burrows
  • John Westwick
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 305)

Abstract

Chronic inflammation is a feature of the airways of patients exhibiting lung diseases such as asthma, sarcoidosis and bronchitis. This has been recognised from autopsy studies of asthmatic airways (1) and has also been shown to be evident in the airways of asthmatics who have mild asthma (2) or are asymptomatic (3). Bronchial airway hyperreactivity (BHR) to a wide range of pharmacological and physical agents is one of the most characteristic features of asthmatic airways. It is known that intensification of BHR follows antigen challenge in atopic asthmatics (4) and it has been widely presumed that inflammatory events during late-onset reactions may determine the changes in airway reactivity (5).

Keywords

Eosinophil Infiltration Atopic Asthmatic Airway Eosinophil Asthmatic Airway Major Basic Protein 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Dunnill, M.S. 1960. The pathology of asthma, with special reference to changes in the bronchial mucosa. J. Clin. Pathol. 13: 27–33.PubMedCrossRefGoogle Scholar
  2. 2.
    Laitinen, L.A., M. Heino, A. Laitinen, T. Kava, and T. Haahtela. 1985. Damage of the airway epithelium and bronchial reactivity in patients with asthma. Am. Rev. Respir. Dis. 131: 599–606.PubMedGoogle Scholar
  3. 3.
    Beasley, R., W.R. Roche, G.A. Roberts, and S.T. Holgate. 1989. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am. Rev. Respir. Dis. 139: 806–817.PubMedGoogle Scholar
  4. 4.
    Cockcroft, D.W., R.E. Ruffm, J. Dolovich, and F.E. Hargreave. 1977. Allergen induced increase in non-allergic bronchial reactivity. Clin. Allergy 7: 503–513.PubMedCrossRefGoogle Scholar
  5. 5.
    Chung, K.F. 1986. Role of inflammation in the hyperreactivity of the airways in asthma. Thorax 41: 657–662.PubMedCrossRefGoogle Scholar
  6. 6.
    Frigas, E., and G.J. Gleich. 1986. The eosinophil and the pathophysiology of asthma. J. Allergy Clin. Immunol. 77: 527–537.PubMedCrossRefGoogle Scholar
  7. 7.
    Horn, B.R., E.D. Robin, J. Theodore, and A. Van Kessel. 1975. Total eosinophil counts in the management of asthma. New Engl. J. Med. 292: 1152–1155.PubMedCrossRefGoogle Scholar
  8. 8.
    De Monchy, J.G.R., H.F. Kauffman, P. Venge, G.H. Koeter, H.M. Jansen, J. Suiter, and K. de Vries. 1985. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am. Rev. Respir. Dis. 131: 373–376.PubMedGoogle Scholar
  9. 9.
    Booij-Noord, H.J., N.G.M. Orie, and K. de Vries. 1971. Immediate and late bronchial obstructive reactions to inhalations of house dust and protective effects of disodium cromoglycate and prednisolone. J. Allergy Clin. Immunol. 48: 344–354.PubMedCrossRefGoogle Scholar
  10. 10.
    Durham, S.R., and A.B. Kay. 1985. Eosinophils, bronchial hyperreactivity and late phase asthmatic reactions. Clin. Allergy 15: 411–418.PubMedCrossRefGoogle Scholar
  11. 11.
    Barnes, PJ., K.F. Chung, and C.P. Page. 1988. Inflammatory mediators in asthma. Pharmacol. Rev 40: 49–84.PubMedGoogle Scholar
  12. 12.
    Gleich, G.J., and C.R. Adolphson. 1986. The eosinophilic leukocyte: structure and function. Adv. Immunol. 39: 177–182.PubMedCrossRefGoogle Scholar
  13. 13.
    Gleich, G.J., E. Frigas, D.A. Loegering, D.L. Wasson, and D. Steinmuller. 1979. Cytotoxic effects of the eosinophil major basic protein. J. Immunol. 123: 2925–2927.PubMedGoogle Scholar
  14. 14.
    Frigas, E., D.A. Loegering, G.O. Solley, G.M. Farrow, and G.J. Gleich. 1981. Elevated levels of eosinophil granule major basic protein in the sputum of patients with bronchial asthma. Mayo Clinic. Proc. 56: 345–353.Google Scholar
  15. 15.
    Flavahan, N.A., N.R. Slifman, G.J. Gleich, and P.M. Vanhoutte. 1988. Human eosinophil major basic protein causes hyperreactivity of respiratory smooth muscle: Role of the epithelium. Am. Rev. Respir. Dis. 138: 685–688.PubMedGoogle Scholar
  16. 16.
    Frigas, E., D.A. Loegering, and G.J. Gleich. 1980. Cytotoxic effects of the guinea-pig eosinophil major basic protein on tracheal epithelium. Lab. Invest. 42: 35–43.PubMedGoogle Scholar
  17. 17.
    Henocq, E., and B.B. Vargaftig. 1988. Skin eosinophilia in atopic patients. J. Allergy Clin. Immunol. 81: 691–695.PubMedCrossRefGoogle Scholar
  18. 18.
    Cuss, F.M., C.M.S. Dixon, and PJ. Barnes. 1986. Effects of inhaled platelet-activating factor on pulmonary function and bronchial responsiveness in man. Lancet 2: 189–192.PubMedCrossRefGoogle Scholar
  19. 19.
    Sanjar, S., S. Aoki, K. Boubekeur, I.D. Chapman, D. Smith, M.A. Kings, and J. Morley. 1990. Eosinophil accumulation in pulmonary airways of guinea-pigs induced by exposure to an aerosol of platelet-activating factor: Effect of anti-asthma drugs. Br. J. Pharmacol. 99: 267–272.PubMedGoogle Scholar
  20. 20.
    Coyle, A.J., S.C. Urwin, C.P. Page, C. Touvay, B. Villain, and P. Braquet. 1988. The effect of the selective PAF antagonist BN 52021 on PAF-induced and antigen-induced bronchial hyperreactivity and eosinophil accumulation. Eur. J. Pharmacol. 148: 51–58.PubMedCrossRefGoogle Scholar
  21. 21.
    Basten, A., and P.B. Beeson. 1970. Mechanism of eosinophilia. II. Role of the lymphocyte. J. Exp. Med. 131: 1288–1294.PubMedCrossRefGoogle Scholar
  22. 22.
    Vadas, M.A., A.F. Lopez, M.F. Shannon, and I. Clark-Lewis. 1989. Regulation of eosinophilopoiesis in man. In Eosinophils in Asthma. J. Morley, and I.G. Colditz, editors. Academic Press, London. 1–11.Google Scholar
  23. 23.
    Baggiolini, M., A. Walz, S.L. Kunkel. 1990. Neutrophil activating peptide -1/interleukin 8, a novel cytokine that activates human neutrophils. J. Clin. Invest. 84: 1045–1050.CrossRefGoogle Scholar
  24. 24.
    Bacon, K.B., J. Westwick, and R.D.R. Camp. 1989. Potent and specific inhibition of IL-8, IL-1α- and IL-1β-induced in vitro human lymphocyte migration by calcium channel antagonists. Biochem. Biophys. Res. Commun. 165: 349–354.PubMedCrossRefGoogle Scholar
  25. 25.
    Larsen, C.G., A.O. Anderson, A. Apella, J.J. Oppenheim, and K. Matsushima. 1989. The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. Science 243: 1464–1466.PubMedCrossRefGoogle Scholar
  26. 26.
    Corrigan, C.J., A. Hartnell, and A.B. Kay. 1988. T Lymphocyte activation in acute severe asthma Lancet i, 1129–1132.CrossRefGoogle Scholar
  27. 27.
    Strieter, R.M., S.L. Kunkel, H.J. Showell, and R.M. Marks. 1988. Monokine-induced gene expression of a human endothelial cell derived neutrophil chemotactic factor. Biochem. Biophys. Res. Commun. 156: 1340–1345.PubMedCrossRefGoogle Scholar
  28. 28.
    Eber, V.M., R.M. Strieter, S.G. Einer, M. Baggiolini, I. Lindley, and S.L. Kunkel. 1990. Neutrophil chemotactic factor (IL-8) gene expression by cytokine-treated retinal pigment epithelial cells. Am. J. Pathol. 136: 4, 745–750.Google Scholar
  29. 29.
    Richerson, H.B. 1972. Acute experimental hypersensitivity pneumonitis in the guinea-pig. J. Lab. Clin. Med. 79: 745–757.PubMedGoogle Scholar
  30. 30.
    Sanjar, S., S. Aoki, A. Kristersson, D. Smith, and J. Morley. 1990. Antigen challenge induces pulmonary airway eosinophil accumulation and airway hyperreactivity in sensitised guinea-pigs: the effect of anti-asthma drugs. Br. J. Pharmacol. 99: 679–686.PubMedGoogle Scholar
  31. 31.
    Maccia, C.A. 1977. Platelet thrombopathy in asthmatic patients with elevated immunoglobulin E. J. Allergy Clin. Immunol. 59: 101–108.PubMedCrossRefGoogle Scholar
  32. 32.
    Gallagher, J.S., I.L. Bernstein, C.A. Maccia, G.L. Splansky, and H.I. Glueck. 1978. Cyclic platelet dysfunction in IgE-mediated allergy. J. Allergy Clin. Immunol. 62: 229–235.PubMedCrossRefGoogle Scholar
  33. 33.
    Slater, D.N., J.F. Martin, and E.A. Trowbridge. 1985. The platelet in asthma. Lancet i:110–111.CrossRefGoogle Scholar
  34. 34.
    Knauer, K.A., L.M. Lichenstein, N.F. Adkinson, and J.E. Fish. 1981. Platelet activation during antigen-induced airway reactions in asthmatic subjects. New Engl. J. Med. 304: 1404–1407.PubMedCrossRefGoogle Scholar
  35. 35.
    Gresele, P., T. Todisco, F. Merante, and G.G. Nenci. 1982. Platelet activation and allergic asthma. New Engl. J. Med. 306: 549–549.PubMedGoogle Scholar
  36. 36.
    Walz, A., and M. Baggiolini. 1990. Generation of the neutrophil-activating peptide NAP-2 from platelet basic protein or connective tissue-activating peptide III through monocyte proteases. J. Exp. Med. 171: 449–454.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1991

Authors and Affiliations

  • Diana Smith
    • 1
  • Lisa Burrows
    • 1
  • John Westwick
    • 1
  1. 1.Department of Pharmacology, Hunterian InstituteRoyal College of SurgeonsLondonUK

Personalised recommendations